GFAP and Alzheimer disease: Therefore, with the aim to verify whether chronic treatment with α-GPC could affect reactive gliosis features, expression of GFAP and iNOS (Asiimwe et al., 2016) was evaluated in brain tissues (cortex and hippocampus) of 3xTg-AD mice.